# Correction to: Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study

PMC · DOI: 10.1093/jbmr/zjae077 · Journal of Bone and Mineral Research · 2024-05-22

## Full-text entities

- **Diseases:** postmenopausal osteoporosis (MESH:D010024)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11301714/full.md

---
Source: https://tomesphere.com/paper/PMC11301714